The study was published in November 2000, almost four years before Merck stopped selling the drug amid safety concerns.The Vioxx accusation came from Dr. Gregory D. Curfman, the editor of The New England Journal of Medicine, who said the authors of a Vioxx study had deleted data about strokes, heart attacks and other vascular problems suffered by some patients.